Caspase-1, a cysteine protease, is critical for the production of mature IL-1β and IL-18, two pro-inflammatory cytokines that play an important role in host defense, sepsis, and the pathogenesis of several inflammatory diseases. In addition, dysregulated IL-1β production is major factor in the development of autoinflammatory disorders including familial cold autoinflammatory syndrome, Muckle-Wells syndrome, and neonatal-onset multiple-system inflammatory disease. These inherited autoinflammatory syndromes are caused by missense mutations in NLRP3, a member of the NOD-like receptor (NLR) family. NLR family members including NOD1, NOD2, NLRC4 and NLRP3 are intracellular proteins that are involved in the recognition of microbial components and activation of inflammatory pathways against invading pathogens. Recent work from several laboratories including our own indicate that NLRP3 is critical for the activation of caspase-1 through its interaction with the adaptor molecule ASC and the formation of the inflammasome, a molecular platform that drives caspase-1 activation. We have obtained evidence that NLRP3 plays an important role in the activation of caspase-1 and IL-1β secretion in response to Toll-like receptor (TLR) ligands as well as infection with Staphylococcus aureus and Streptococcus pyogenes, two significant human pathogens. In addition, NLRP3 is critical for the activation of caspase-1 in response to particulate matter including silica and urate crystals. However, the molecular mechanism by which microbial and endogenous stimuli trigger caspase-1 activation via NLRP3 remains poorly understood. Our preliminary results revealed that TLR ligands and certain cytokines including TNF-α, IL-1α and IL-1β promote NLRP3-dependent caspase-1 activation, at least in part, via NF-κB activation. Unlike TLR agonists, we found that S. aureus and S. pyogenes activate the NLRP3 inflammasome via pore-forming toxins but independently of MyD88/TRIF and the purinergic P2X7 receptor. The goal of this proposal is to provide a better understanding of the molecular mechanism governing NLRP3 activation and the role of the NLRP3 inflammasome in host defense. Biochemical, genetic, and cellular approaches will be employed to study the function and activation of NLRP3. Given the important role of IL-1β in immunity and inflammatory disease, understanding of the mechanism involved in caspase-1 activation and IL-1β production via NLRP3 is expected to have a significant impact in the medical field

Public Health Relevance

The NLRP3 inflammasome is critical for host defense and contributes to inflammatory responses in response to microbial and endogenous stimuli. Furthermore, NLRP3 is dysregulated by germline mutations mutation in autoinflammatory syndromes and participates in the pathogenesis of several inflammatory disorders including gout and Crohn?s disease. The main goal of this proposal is to understand the formation, regulation and activation of the NLRP3 inflammasome in response to endogenous signals and infectious agents. These studies may lead to better understanding of mechanisms that control host defense against human pathogens and inflammatory disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
High Priority, Short Term Project Award (R56)
Project #
2R56AI063331-06
Application #
8083029
Study Section
Innate Immunity and Inflammation Study Section (III)
Program Officer
Minnicozzi, Michael
Project Start
2010-06-21
Project End
2011-05-31
Budget Start
2010-06-21
Budget End
2011-05-31
Support Year
6
Fiscal Year
2010
Total Cost
$386,250
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Pathology
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Bronner, Denise N; Abuaita, Basel H; Chen, Xiaoyun et al. (2015) Endoplasmic Reticulum Stress Activates the Inflammasome via NLRP3- and Caspase-2-Driven Mitochondrial Damage. Immunity 43:451-62
De la Fuente, Marjorie; Franchi, Luigi; Araya, Daniela et al. (2014) Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome. Int J Med Microbiol 304:384-92
Muñoz-Planillo, Raúl; Kuffa, Peter; Martínez-Colón, Giovanny et al. (2013) K? efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38:1142-53
Embry, Chelsea A; Franchi, Luigi; Nuñez, Gabriel et al. (2011) Mechanism of impaired NLRP3 inflammasome priming by monophosphoryl lipid A. Sci Signal 4:ra28
Shaw, Michael H; Kamada, Nobuhiko; Warner, Neil et al. (2011) The ever-expanding function of NOD2: autophagy, viral recognition, and T cell activation. Trends Immunol 32:73-9
Chen, Grace Y; Núñez, Gabriel (2011) Inflammasomes in intestinal inflammation and cancer. Gastroenterology 141:1986-99
Reimer, Thornik; Shaw, Michael H; Franchi, Luigi et al. (2010) Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome. Eur J Immunol 40:764-9
Franchi, Luigi; Muñoz-Planillo, Raul; Reimer, Thornik et al. (2010) Inflammasomes as microbial sensors. Eur J Immunol 40:611-5
Toma, Claudia; Higa, Naomi; Koizumi, Yukiko et al. (2010) Pathogenic Vibrio activate NLRP3 inflammasome via cytotoxins and TLR/nucleotide-binding oligomerization domain-mediated NF-kappa B signaling. J Immunol 184:5287-97
Masters, Seth L; Dunne, Aisling; Subramanian, Shoba L et al. (2010) Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1? in type 2 diabetes. Nat Immunol 11:897-904

Showing the most recent 10 out of 17 publications